Explore the evolution of vaccine technology from Jenner to mRNA, highlighting India's role in COVID-19 vaccine development.

The family office of the founders of Bharat Biotech International Ltd, the maker of Covid-19 vaccine Covaxin, has invested in two companies even as it plans to raise a new investment fund and expand ...

The vaccine is to combine GSK’s injectable polio vaccine (IPV) and Biological E’s pentavalent vaccine for diphtheria, tetanus, whooping cough (whole cell pertussis), hepatitis B, and ...

It will allow health workers to administer vaccines with the aim of reaching some 640,000 Palestinian children. The vaccination campaign comes after the first polio case in 25 years in Gaza was ...

Bharat Immunological & Biologicals Corporation Ltd. key Products/Revenue Segments include Oral Polio Vaccines for the year ending 31-Mar-2022.For the quarter ended 30-09-2023, the company has reported ...

The Chilean government bet big on Sinovac’s Covid-19 vaccine, part-funding along with local businesses CoronaVac’s trial in the country, and in 2021 ordered 60 million doses of the drug over ...

A COVID-19 vaccine developed using the technology cleared a phase 1 proof-of-concept study in Australia, but Vicebio is focusing first on RSV, with clinical trials of VXB-211 scheduled to in the ...

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

(AP Photo) A health worker, left, administers a polio vaccine to a child at a neighborhood in Peshawar, Pakistan, Monday, Feb. 3, 2025. (AP Photo/Muhammad Sajjad) A health worker, right ...

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Government institutions and professional traders are banking on biotech stocks to continually develop a vaccine and boosters that can eradicate COVID-19. Tilt your stock portfolio toward biotech ...